Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a novel coronavirus (MERS‐ CoV) that was first identified in Saudi Arabia in 2012.
MERS (Middle East Respiratory Syndrome) is a severe pneumonia-like respiratory disease caused by a virus. It is different from SARS because MERS is caused by another subtype of the virus.
Coronaviruses are a large family of viruses that can cause diseases ranging from the common cold to Severe Acute Respiratory Syndrome (SARS).
MERS – Middle East Respiratory Syndrome – Highlights
Approximately 36% of reported patients with MERS have died.
Although in recent outbreak majority of human cases of MERS have been attributed to human-to-human infections, camels are likely to be a major reservoir host for MERSCoV and an animal source of MERS infection in humans. However, the exact role of camels in transmission of the virus and the exact route(s) of transmission are unknown.
The virus does not seem to pass easily from person to person unless there is close contact, such as occurs when providing unprotected care to a patient.
MERS is different from SARS. Most importantly, the MERS virus does not appear to be as easily spread between people, whereas the SARS virus spreads very easily.
MERS causes high fever, cough, and severe shortness of breath. The infection is thought to be spread by close contact with an infected person.
MERS – Middle East Respiratory Syndrome – Symptoms
The clinical spectrum of MERS-CoV infection ranges from no symptoms (asymptomatic) or mild respiratory symptoms to severe acute respiratory disease and death. A typical presentation of MERS-CoV disease is fever, cough and shortness of breath. Pneumonia is a common finding, but not always present.
Gastrointestinal symptoms, including diarrhoea, have also been reported. Severe illness can cause respiratory failure that requires mechanical ventilation and support in an intensive care unit.
Approximately 36% of reported patients with MERS-CoV have died.
The virus appears to cause more severe disease in older people, people with weakened immune systems, and those with chronic diseases such as cancer, chronic lung disease and diabetes.
Pneumonia is a general term for an inflammation of the air sacs of the lungs caused by an infection or chemical. With pneumonia, the lungs fill with fluid, which interferes with their ability to transfer oxygen to the blood. MERS is known as an atypical pneumonia because it is not caused by the usual bacteria or viruses.
MERS – Middle East Respiratory Syndrome – Source of the virus
MERS-CoV is a zoonotic virus that is transmitted from animals to humans. The origins of the virus are not fully understood but, according to the analysis of different virus genomes, it is believed that it originated in bats and was transmitted to camels sometime in the distant past.
Non-human to human transmission:
The route of transmission from animals to humans is not fully understood, but camels are likely to be a major reservoir host for MERS-CoV and an animal source of infection in humans.
Strains of MERS-CoV that are identical to human strains have been isolated from camels in several countries
The virus does not appear to pass easily from person to person unless there is close contact, such as providing unprotected care to an infected patient.
There have been clusters of cases in healthcare facilities, where human-to-human transmission appears to be more probable, especially when infection prevention and control practices are inadequate. Thus far, no sustained community transmission has been documented.
The virus appears to be circulating throughout the Arabian Peninsula, primarily in Saudi Arabia, where the majority of cases (>85%) have been reported since 2012.
Several cases have been reported outside the Middle East. Most of these infections are believed to have been acquired in the Middle East, and then exported outside the region. The ongoing outbreak in the Republic of Korea is the largest outbreak outside of the Middle East, and while concerning, there is no evidence of sustained human to human transmission in the Republic of Korea.
For all other exported cases, no secondary or limited secondary transmission has been reported in countries with exported cases.
Prevention and treatment
No vaccine or specific treatment is currently available. Treatment is supportive and based on the patient’s clinical condition.
As a general precaution, anyone visiting farms, markets, barns, or other places where camels and other animals are present should practice general hygiene measures, including regular hand washing before and after touching animals, and should avoid contact with sick animals.
The consumption of raw or undercooked animal products, including milk and meat, carries a high risk of infection from a variety of organisms that might cause disease in
Animal products that are processed appropriately through cooking or pasteurization are safe for consumption, but should also be handled with care to avoid cross contamination with uncooked foods. Camel meat and camel milk are nutritious products that can continue to be consumed after pasteurization, cooking, or other heat treatments.
These people should avoid contact with camels, drinking raw camel milk or camel urine, or eating meat that has not been properly cooked.
Transmission of the virus has occurred in health‐ care facilities in several countries, including from patients to health‐ care providers and between patients in a health care setting before MERS-CoV was diagnosed. It is not always possible to identify patients with MERS‐ CoV early or without testing because symptoms and other clinical features
may be non‐ specific.
Infection prevention and control measures are critical to prevent the possible spread of MERS‐ CoV in health‐ care facilities. Facilities that provide care for patients suspected or confirmed to be infected with MERS‐ CoV should take appropriate measures to decrease the risk of transmission of the virus from an infected patient to other patients, health‐ care workers, or visitors. Health‐ care workers should be educated and trained in infection prevention and control and should refresh these skills regularly.
WHO does not recommend the application of any travel or trade restrictions or entry screening related to MERS-CoV.
WHO encourages all countries to enhance their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns of SARI or pneumonia cases.